Europe/India/Near East USA Asia
Bachem AG Bachem Americas, Inc. Bachem Japan K.K.
Hauptstrasse 144 3132 Kashiwa Street AREA Shinagawa, 13F
4416 Bubendorf - Switzerland Torrance, CA 90505 - USA Tokyo 108-0075 - Japan
Tel +41 58 595 2021 Tel +1 888 422 2436 Tel +81 3 4405 3141
Fax +41 58 595 2040 Tel +1 888 4BACHEM Email sales.jp@bachem.com
Email sales.ch@bachem.com Fax +1 310 539 9428  
  E-mail sales.us@bachem.com  

PEPTIDE PURITY

Peptide Purity

  • Our comprehensive range of high-quality amino acid derivatives available from stock allows us to carry out orders of unusual peptides according to your specificatons rapidly.
  • All custom peptides are manufactured at our state-of-the-art facilities.
  • Our custom-synthesized peptides are characterized by amino acid analysis and mass spectrometry. Their purity is determined by analytical RP-HPLC. A Certificate of Analysis containing these data will be made available to you upon delivery.

 

As the price of custom peptides will grow considerably with increasing purity demands, customers should order the purity required for their application. Our recommendations are:
 

Purity
Applications
 
>95%
  • NMR studies
  • Crystallography studies
  • Peptides used as reference in final quantitative studies
  • Enzyme-substrate studies
  • Receptor-ligand interaction studies
  • Blocking and competition assays
 
90-95%
  • Production of monoclonal antibodies
  • Enzyme-substrate studies (quantitative)
  • Receptor-ligand interaction studies (quantitative)
  • Blocking and competition assays
    • ELISA and RIA (quantitative)
    • In vivo/in vitro studies
 
>80%
  • Western blotting studies (non-quantitative)
  • Enzyme-substrate studies (non-quantitative)
  • Phosphorylation studies
 
Immunograde
  • Production of polyclonal antibodies
>65%
  • Determination of the titer of antibodies in standard ELISA

 

 

 

When your project requirements advance from research scale to process development and cGMP manufacturing, Bachem is ready to support you with our framework of cGMP production facilities and dedicated regulatory affairs staff.